SCHWARZ PHARMA AG / Squeeze Out 08.05.2009 Release of a Adhoc News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Ad-hoc announcement pursuant to sec. 15 May 8, 2009 German Securities Trading Act (WpHG) _______________________________________________________________________ SCHWARZ PHARMA AG: Squeeze-out cash compensation determined at EUR 111,44 per share UCB SP GmbH has informed the SCHWARZ PHARMA AG Executive Board today by specifying its transfer request letter as of February 6, 2009 that it has determined the cash compensation to be paid for the transfer of the shares held by the minority shareholders of SCHWARZ PHARMA AG to the majority shareholder UCB SP GmbH according to § 327a German stock corporation act (squeeze-out) at EUR 111,44 per share. The squeeze-out requires the approval of the SCHWARZ PHARMA AG shareholder meeting which is scheduled for July 8, 2009. _______________________________________________________________________ SCHWARZ PHARMA Aktiengesellschaft Alfred-Nobel-Str. 10 40789 Monheim Deutschland Investor Relations: Sylvia Heitzer, Tel.: +49 21 73 48 12 38 ISIN: DE0007221905 WKN: 722190 Listed: Regulierter Markt in Frankfurt (General Standard) End of News Contact: Corporate Communications: Sylvia Heitzer, Tel: +49 2173 48 1238; DGAP 08.05.2009 --------------------------------------------------------------------------- Language: English Issuer: SCHWARZ PHARMA AG Alfred-Nobel-Str. 10 40789 Monheim Deutschland Phone: +49 2173 48 1866 Fax: +49 2173 48 1856 E-mail: antje.witte@ucb.com Internet: www.ucb-group.com ISIN: DE0007221905 WKN: 722190 Listed: Regulierter Markt in Frankfurt (General Standard), Düsseldorf; Freiverkehr in Berlin, Hannover, München, Hamburg, Stuttgart End of News DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: SCHWARZ PHARMA AG: Squeeze-out cash compensation determined at EUR 111,44 per share
| Source: EQS Group AG